1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 15
1.3 SCOPE OF THE STUDY 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY SOURCES 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY SOURCES 23
2.1.2.1 Key data from primary sources 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 MARKET SHARE ESTIMATION 29
2.5 ASSUMPTIONS FOR THE STUDY 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 33
4.1 EUROPEAN MEDICAL DEVICES MARKET OVERVIEW 33
4.2 EUROPEAN MEDICAL DEVICES MARKET, BY END USER & COUNTRY (2019) 34
4.3 COUNTRY MIX: EUROPEAN MEDICAL DEVICES MARKET 35
4.4 EUROPEAN MEDICAL DEVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 KEY MARKET DRIVERS 37
5.2.1.1 Rising geriatric population 37
5.2.1.2 Large and established medical technology industry 38
5.2.1.3 Increasing number of surgical procedures 39
5.2.1.4 Availability of funding for research and product innovation 40
5.2.1.5 Growing need for cost-containment in the healthcare industry 41
5.2.2 RESTRAINTS 41
5.2.2.1 Fiscal unsustainability due to wasteful spending 41
5.2.3 OPPORTUNITIES 42
5.2.3.1 Growing demand for out-of-hospital care 42
5.2.3.2 Emerging markets across Central and Eastern Europe 42
5.2.4 CHALLENGES 43
5.2.4.1 Compliance issues with new MDR regulations 43
5.2.4.2 Non-compliance to the Golden Rule 43
5.2.5 BURNING ISSUES 44
5.2.5.1 Postponement of non-emergency elective surgeries 44
5.2.5.2 Medical device supply chain disruption 44

6 INDUSTRY INSIGHTS 45
6.1 IMPACT OF COVID-19 ON THE EUROPEAN MEDICAL DEVICES MARKET 45
6.2 RECLASSIFICATION OF MEDICAL DEVICES UNDER THE NEW MDR REGULATIONS 45
6.2.1 CLASSIFICATION OF NON-INVASIVE DEVICES 46
6.2.2 CLASSIFICATION ON INVASIVE DEVICES 46
6.2.3 CLASSIFICATION OF ACTIVE DEVICES 48
6.2.4 CLASSIFICATION OF NANOMATERIALS 49
6.2.5 SPECIAL RULES 50
6.3 MANAGED EQUIPMENT SERVICE PROVIDERS AND GROUP PURCHASING 51
6.4 REMOTE PATIENT MANAGEMENT 52
6.5 USE OF ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICES 52

7 EUROPEAN MEDICAL DEVICES MARKET, BY DEVICE TYPE 53
7.1 INTRODUCTION 54
7.2 ORTHOPEDIC DEVICES 55
7.3 ENDOSCOPY DEVICES 56
7.4 DIAGNOSTIC IMAGING SYSTEMS 59
7.5 INTERVENTIONAL CARDIOLOGY DEVICES 64
7.6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES 66
7.7 OPHTHALMIC DEVICES 68
7.8 RESPIRATORY CARE DEVICES 70
7.9 DIALYSIS DEVICES 72
7.10 DIABETES CARE DEVICES 73
7.11 ANESTHESIA MONITORING DEVICES 75
7.12 VENTILATORS 76

8 MEDICAL DEVICES MARKET, BY END USER 78
8.1 INTRODUCTION 79
8.2 HOSPITALS AND CLINICAL CARE SETTINGS 79
8.3 HOME CARE SETTINGS 80

9 MEDICAL DEVICES MARKET, BY REGION 81
9.1 INTRODUCTION 82
9.2 GERMANY 83
9.2.1 GERMANY IS THE LARGEST MARKET FOR MEDICAL DEVICES IN EUROPE 83
9.3 UK 86
9.3.1 UTILIZATION OF HOSPITAL SERVICES IS 25% LOWER IN THE UK THAN THE EU AVERAGE 86
9.4 FRANCE 90
9.4.1 TECHNOLOGICAL EXPERTISE AND INNOVATIONS ARE ATTRACTING MARKET PLAYERS TO COMPETE IN THE MEDICAL DEVICES MARKET IN FRANCE 90
9.5 ITALY 94
9.5.1 REGIONAL AND ECONOMIC DISPARITIES IN THE COUNTRY CAN HAMPER THE GROWTH OF THE HEALTHCARE INDUSTRY 94
9.6 SPAIN 98
9.6.1 GROWING DEMAND FOR PRIMARY CARE TO DRIVE MARKET GROWTH IN SPAIN 98
9.7 POLAND 101
9.7.1 RISING GERIATRIC POPULATION AND INCREASING DEMAND FOR HOME HEALTHCARE TO DRIVE MARKET GROWTH IN POLAND 101
9.8 REST OF EUROPE 103

10 COMPETITIVE LANDSCAPE 106
10.1 INTRODUCTION 106
10.2 COMPETITIVE SITUATION AND TRENDS 108
10.2.1 PRODUCT LAUNCHES 108
10.2.2 ACQUISITIONS 108
10.2.3 OTHER DEVELOPMENTS 109

11 COMPANY PROFILES 110
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 SIEMENS HEALTHINEERS (SUBSIDIARY OF SIEMENS GROUP) 110
11.2 GE HEALTHCARE 115
11.3 PHILIPS 122
11.4 ABBOTT 128
11.5 ASAHI KASEI 131
11.6 B. BRAUN MELSUNGEN AG 133
11.7 BAXTER INTERNATIONAL 139
11.8 BOSTON SCIENTIFIC CORPORATION 142
11.9 MEDTRONIC 147
11.10 SMITH & NEPHEW 153
11.11 STRYKER CORPORATION 155
11.12 RESMED 158
11.13 MASIMO 160
11.14 KARL STORZ 163
11.15 OTHER COMPANIES 166
11.15.1 VIMEX ENDOSCOPY 166
11.15.2 ENDOTEC MEDICAL SYSTEMS 166
11.15.3 THERAPIXEL 167
11.15.4 MULTIWAVE IMAGING SA 167
11.15.5 QUANTA DIALYSIS TECHNOLOGIES 167
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX 168
12.1 INSIGHTS OF INDUSTRY EXPERTS 168
12.2 DISCUSSION GUIDE 169
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 172
12.4 AVAILABLE CUSTOMIZATIONS 174
12.5 RELATED REPORTS 174
12.6 AUTHOR DETAILS 175

LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES 20
TABLE 2 EU: MACROECONOMIC AND INFRASTRUCTURAL INDICATORS 38
TABLE 3 EXAMINATIONS PERFORMED PER 100,000 INHABITANTS USING IMAGING EQUIPMENT IN HOSPITALS AND AMBULATORY CARE CENTERS 39
TABLE 4 EUROPE: WASTEFUL SPENDING, BY COUNTRY 41
TABLE 5 SURGICAL CASE TYPES BASED ON INDICATION AND URGENCY 44
TABLE 6 EUROPE: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 54
TABLE 7 NUMBER OF HIP AND KNEE REPLACEMENT SURGICAL PROCEDURES (2011 VS. 2017) 55
TABLE 8 EUROPE: ORTHOPEDIC DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 55
TABLE 9 NUMBER OF ENDOSCOPY PROCEDURES, BY TYPE (2018) 56
TABLE 10 EUROPE: ENDOSCOPY DEVICES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 57
TABLE 11 EUROPE: ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 57
TABLE 12 EUROPE: ENDOSCOPES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 57
TABLE 13 EUROPE: VISUALIZATION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 14 EUROPE: OTHER ENDOSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 15 EUROPE: ENDOSCOPY ACCESSORIES MARKET, BY COUNTRY, 2028–2025 (USD MILLION) 59
TABLE 16 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES 59
TABLE 17 PERCENT INCREASE OF DIAGNOSTIC IMAGING UNITS IN HOSPITALS AND AMBULATORY HEALTH CENTERS PER 100,000 INHABITANTS, BY COUNTRY (2013 VS. 2017) 60
TABLE 18 EUROPE: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 61
TABLE 19 EUROPE: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 20 EUROPE: X-RAY SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 21 EUROPE: MRI SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 22 EUROPE: ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 23 EUROPE: CT SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 24 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY END USER, 2018–2025 (USD MILLION) 64
TABLE 25 EUROPE: MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 64
TABLE 26 NUMBER OF DEATHS DUE TO ISCHEMIC HEART DISEASE, 2017 65
TABLE 27 NUMBER OF SURGICAL OPERATIONS AND PROCEDURES RELATED TO THE CIRCULATORY SYSTEM, PER 100,000 INHABITANTS (IN 2017) 65
TABLE 28 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 29 PREVALENCE OF FACTORS THAT AFFECT CVD IN ESC MEMBER COUNTRIES 67
TABLE 30 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 67
TABLE 31 PREVALENCE OF AGE-RELATED MACULAR DEGENERATION IN THE GERIATRIC POPULATION (50 YEARS & ABOVE), BY COUNTRY, 2013 VS. 2023 69
TABLE 32 TOTAL NUMBER OF CATARACT SURGERIES PERFORMED IN 2015 AND 2017, BY COUNTRY 69
TABLE 33 NUMBER OF GLAUCOMA PATIENTS, BY COUNTRY, 2013 VS. 2020 VS.2040 (IN MILLION) 69
TABLE 34 DIABETES POPULATION IN EUROPE, 2017 VS. 2045 (MILLION) 69
TABLE 35 EUROPE: OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 36 GEOGRAPHIC PREVALENCE OF COPD ACROSS EUROPE, 2017 71
TABLE 37 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 71
TABLE 38 PREVALENCE OF RRT ACROSS EUROPEAN COUNTRIES, 2015–2017 72
TABLE 39 EUROPE: DIALYSIS DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 73
TABLE 40 NUMBER OF ADULTS (AGED 20-79) WITH DIABETES (IN THOUSAND) 74
TABLE 41 EUROPE: DIABETES CARE DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 75
TABLE 42 EUROPE: ANESTHESIA MONITORING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 43 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 44 EUROPE: MEDICAL DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION) 79
TABLE 45 EUROPE: MEDICAL DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 46 GERMANY: MACROECONOMIC FACTORS AFFECTING THE MEDICAL DEVICES MARKET 84
TABLE 47 GERMANY: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 85
TABLE 48 GERMANY: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 86
TABLE 49 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 86
TABLE 50 UK: MACROECONOMIC FACTORS AFFECTING THE MEDICAL DEVICES MARKET 87
TABLE 51 UK: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 89
TABLE 52 UK: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 89
TABLE 53 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 90
TABLE 54 FRANCE: MACROECONOMIC FACTORS AFFECTING THE MEDICAL DEVICES MARKET 92
TABLE 55 FRANCE: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 93
TABLE 56 FRANCE: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 57 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 94
TABLE 58 ITALY: NUMBER OF ELDERLY PEOPLE WITH ATRIAL FIBRILLATION (IN THOUSAND) 95
TABLE 59 ITALY: MACROECONOMIC FACTORS AFFECTING THE MEDICAL DEVICES MARKET 96
TABLE 60 ITALY: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 97
TABLE 61 ITALY: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 97
TABLE 62 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 63 SPAIN: MACROECONOMIC FACTORS AFFECTING THE MEDICAL DEVICES MARKET 99
TABLE 64 SPAIN: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 100
TABLE 65 SPAIN: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 100
TABLE 66 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 101
TABLE 67 POLAND: MACROECONOMIC FACTORS AFFECTING THE MEDICAL DEVICES MARKET 102
TABLE 68 POLAND: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 102
TABLE 69 POLAND: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 70 POLAND: ENDOSCOPY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 71 ROE: MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 104
TABLE 72 ROE: DIAGNOSTIC IMAGING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 73 ROE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 74 PRODUCT LAUNCHES (2017–2020) 108
TABLE 75 ACQUISITIONS (2017–2020) 108
TABLE 76 JOINT VENTURES AND PARTNERSHIPS (2017–2020) 109

LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 21
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 3 MARKET SIZE ESTIMATION 25
FIGURE 4 REVENUE SHARE ANALYSIS ILLUSTRATION 25
FIGURE 5 DATA TRIANGULATION METHODOLOGY 28
FIGURE 6 EUROPEAN MEDICAL DEVICES MARKET, BY COUNTRY, 2020 VS. 2025 (USD MILLION) 30
FIGURE 7 EUROPEAN MEDICAL DEVICES MARKET, BY DEVICE TYPE, 2020 VS. 2025 (USD MILLION) 31
FIGURE 8 EUROPEAN MEDICAL DEVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 31
FIGURE 9 INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 33
FIGURE 10 GERMANY ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN MEDICAL DEVICES MARKET IN 2019 34
FIGURE 11 GERMANY WILL CONTINUE TO DOMINATE THE EUROPEAN MEDICAL DEVICES MARKET DURING THE FORECAST PERIOD 35
FIGURE 12 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 35
FIGURE 13 EUROPEAN MEDICAL DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 14 EU: DISTRIBUTION OF POPULATION, BY AGE (2010 VS. 2020 VS. 2030) 37
FIGURE 15 DISEASE TRENDS IN EU-28 (AS OF 2016) 37
FIGURE 16 NUMBER OF SURGICAL PROCEDURES PERFORMED IN HOSPITAL SETTINGS 39
FIGURE 17 COMPANIES AND THEIR R&D AS A PERCENTAGE OF REVENUE (2019) 40
FIGURE 18 INCREASING NUMBER OF LONG-TERM CARE BEDS IN NURSING AND RESIDENTIAL CARE FACILITIES TO PROVIDE OPPORTUNITIES IN REMOTE PATIENT MONITORING 42
FIGURE 19 DEVIATION FROM GOLDEN RULE, BY COUNTRY (2018) 51
FIGURE 20 LEADING CAUSES OF DISEASE-RELATED DEATHS IN GERMANY (AS OF 2017) 83
FIGURE 21 LEADING CAUSES OF DISEASE-RELATED DEATHS IN THE UK (AS OF 2017) 87
FIGURE 22 LEADING CAUSES OF DISEASE-RELATED DEATHS IN FRANCE (AS OF 2017) 90
FIGURE 23 LEADING CAUSES OF DISEASE-RELATED DEATHS IN ITALY (AS OF 2017) 94
FIGURE 24 LEADING CAUSES OF DISEASE-RELATED DEATHS IN SPAIN (AS OF 2017) 98
FIGURE 25 LEADING CAUSES OF DISEASE-RELATED DEATHS IN POLAND (AS OF 2017) 101
FIGURE 26 KEY DEVELOPMENTS IN THE EUROPEAN MEDICAL DEVICES MARKET BETWEEN JANUARY 2017 AND APRIL 2020 107
FIGURE 27 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019) 110
FIGURE 28 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2019) 115
FIGURE 29 PHILIPS: COMPANY SNAPSHOT (2019) 122
FIGURE 30 ABBOTT: COMPANY SNAPSHOT (2019) 128
FIGURE 31 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2019) 131
FIGURE 32 B. BRAUN: COMPANY SNAPSHOT (2019) 133
FIGURE 33 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2019) 139
FIGURE 34 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2019) 143
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2019) 147
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2019) 155
FIGURE 37 RESMED: COMPANY SNAPSHOT (2019) 158
FIGURE 38 MASIMO CORPORATION: COMPANY SNAPSHOT (2019) 160